With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
Other topics likely to come up: the Gulf of America, buying (or otherwise negotiating a deal with) Greenland for national security and critical mineral purposes, retaking the Panama Canal and — ...
Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...
Eli Lilly and Company, UnitedHealth Group, AbbVie, Walmart, Johnson & Johnson, Natera, and Gilead Sciences are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool.
Big Pharma executives feel optimistic about their industry’s trajectory under a second Donald Trump presidency, with regulation rollbacks and other changes likely to boost bottom lines for drugmakers, ...
A number of sessions on the second day of IPWatchdog LIVE examined the state of U.S. IP policy and the potential for change ...
On the eve of President Trump's tariffs, Reuters reported Honda would move production of the popular Civic to Indiana. Honda declined to comment.
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
Gov. Gavin Newsom has yet to make good on his promise of state-produced, affordable insulin for diabetics. What's the hold up ...
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
LEQEMBI (lecanemab) has significant market potential due to the high global prevalence of the condition and the demand for disease-modifying treatmen ...
People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback